How This Evidence Evolved
Decompressive Craniectomy in Stroke
From observational benefit to age-stratified evidence and guideline integration
Timeline
Early observations and pilot data that first suggested a new direction
Landmark RCTs and pivotal trials that established the evidence base
mRS ≤3 at 6 months: surgery 25% vs no surgery 5.6% (P=0.18)
Modified Rankin Scale ≤3 at 6 months
Modified Rankin Scale at 12 months
mRS 0–4 vs 5–6 at 1 year
Follow-up studies, subgroup analyses, and real-world validation
Integration into clinical practice guidelines and recommendations
Current standard of care and ongoing research directions
Landmark Trials in This Story
Early hemicraniectomy in patients with complete middle cerebral artery infarction
Survival: 46/63 (73%)
Sequential-design, multicenter, randomized, controlled trial of early decompressive craniectomy in malignant middle cerebral artery infarction (DECIMAL Trial).
mRS ≤3 at 6 months: surgery 25% vs no surgery 5.6% (P=0.18)
Decompressive Surgery for the Treatment of Malignant Infarction of the Middle Cerebral Artery (DESTINY): a randomized, controlled trial
Modified Rankin Scale ≤3 at 6 months
Surgical decompression for space-occupying cerebral infarction (the Hemicraniectomy After Middle Cerebral Artery infarction with Life-threatening Edema Trial [HAMLET]): a multicentre, open, randomised trial
Modified Rankin Scale at 12 months
Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials
mRS 0–4 vs 5–6 at 1 year
Hemicraniectomy in older patients with extensive middle-cerebral-artery stroke
Modified Rankin Scale 0-4 at 6 months (survival without severe disability)
Hemicraniectomy and durotomy upon deterioration from infarction-related swelling trial: randomized pilot clinical trial
Death at 21 days
Explore the evidence yourself
Ask AttendMe about any trial, guideline, or clinical question. Evidence-ranked answers from 3.7M+ peer-reviewed articles.